J. Ahomadegbe

发表

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.

J. Ahomadégbé, G. Riou, J. Riou, 1989, Biochemical pharmacology.

ATP‐independent DNA topoisomerase II as potential drug target in trypanosomes

G. Riou, J. Riou, S. Douc-Rasy, 1988, Biology of the cell.

P73 functionally replaces p53 in Adriamycin‐treated, p53‐deficient breast cancer cells

A. Valent, H. Haddada, S. Tourpin, 2005, International journal of cancer.

[High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].

J. Armand, G. Riou, M. Barrois, 1996, Bulletin du cancer.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

F. Bertucci, D. Birnbaum, P. Finetti, 2008, Oncogene.

Kinetoplast DNA from plant trypanosomatids responsible for the Hartrot disease in coconut trees

G. Riou, M. Dollet, J. Ahomadegbe, 1992 .

p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies.

M. Mathieu, U. Moll, J. Ahomadégbé, 1995, Human pathology.

ETV6 gene rearrangements in invasive breast carcinoma

D. Birnbaum, N. Cervera, C. Ginestier, 2005, Genes, chromosomes & cancer.

Nuclear localization of the caspase-3-cleaved form of p73 in anoikis

F. André, G. Vassal, S. Alsafadi, 2015, Oncotarget.

Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatment.

M. Vayssade, Laetitia Faridoni-Laurens, J. Bénard, 2002, Biochemical pharmacology.

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

J. Armand, G. Riou, M. Barrois, 1995, Oncogene.

Characterization of Phytomonas sp. kinetoplast DNA

J. Ahomadégbé, G. Riou, D. Coulaud, 1987 .

Variability of kinetoplast DNA from plant trypanosomatids responsible for Hartrot and Marchitez diseases

D. Coulaud, C. Fernández-Becerra, M. Dollet, 1995 .

Analysis of fibroblast growth factor receptor 3 G697C mutation in oral squamous cell carcinomas

F. Radvanyi, F. Janot, J. Ahomadégbé, 2007, International journal of cancer.

No evidence of somatic FGFR3 mutation in various types of carcinoma

J. Thiery, F. Radvanyi, E. Brambilla, 2001, Oncogene.

High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.

G. Riou, M. Barrois, J. Coll, 1996, Oncogene.

Involvement of N-terminally truncated variants of p73, ΔTAp73, in head and neck squamous cell cancer: A comparison with p53 mutations

S. Koscielny, J. Bosq, F. Janot, 2008, Cell cycle.

TP53 family members and human cancers

S. Douc-Rasy, S. Douc‐Rasy, J. Bénard, 2003, Human mutation.

Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.

Caroline Even, Fabrice André, F. André, 2013, Clinical breast cancer.

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

M. Kaghad, D. Caput, J. Bosq, 2001, Oncogene.

Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.

J. Ahomadégbé, G. Riou, J. Bénard, 1991, Biochemical pharmacology.

c‐erbB‐2 (HER‐2/neu) gene amplification is a better indicator of poor prognosis than protein over‐expression in operable breast‐cancer patients

M. Mathieu, G. Riou, M. Barrois, 2001, International journal of cancer.

Cisplatin‐induced apoptosis and p53 gene status in a cisplatin‐resistant human ovarian carcinoma cell line

Anne Fajao, J. da Silva, J. Ahomadégbé, 1996, International journal of cancer.

Association of c‐erbB2‐gene amplification with poor prognosis in non‐inflammatory breast carcinomas but not in carcinomas of the inflammatory type

J. Ahomadégbé, G. Riou, M. Spielmann, 1994, International journal of cancer.

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers

L. Zelek, M. Mathieu, M. Kaghad, 2000, Oncogene.

Expression of multidrug-resistance (MDR1) gene in normal epithelia and in invasive carcinomas of the uterine cervix.

G. Riou, P. Duvillard, C. Lhommé, 1990, Journal of the National Cancer Institute.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

F. Bertucci, D. Birnbaum, P. Finetti, 2008, Oncogene.

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

P. Finetti, C. Theillet, B. Orsetti, 2008 .